drugset / Trial / NCT05458479
Fluoxetine Treatment of Depression in Down Syndrome
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to do a preliminary assessment of whether fluoxetine is effective, safe, and tolerable for the treatment of depression in adults with Down syndrome.
Timeline
- Start
- 2022-12-05
- Primary completion
- 2024-02-26
- Completion
- 2024-02-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluoxetine | Small molecule | 30 mg | Oral |